# Pfizer Inc. (PFE) — Q1-2018 Earnings Results

**Report date:** 2018-05-01 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q1-2018

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Down 3.31%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.77 | N/A | +1.66% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Management expressed caution regarding market conditions. They are prioritizing cost management while focusing on their product pipeline.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized a focus on cost management and operational efficiency.

> Future growth will depend on pipeline developments.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Pfizer's earnings report showed a slight beat on EPS, but the stock fell by 3.31% following the announcement. Investors may be concerned about the lack of revenue details and the absence of guidance, which could indicate uncertainty about future performance. The defensive tone from management suggests they are aware of challenges ahead, which may have contributed to the stock's decline.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q1-2018_